This concept paper addresses the need to establish a Guideline on the Development and Manufacture of Synthetic Oligonucleotides. The number of clinical trial applications for human products and marketing authorization applications for synthetic oligonucleotides for both human and veterinary products has significantly increased over the last few years.
Read the pdf